Tumor-infiltrating clonal hematopoiesis (TI-CH) is associated with worse survival among patients with solid tumors, according to a study published online May 7 in JAMA Oncology.
This article was originally published by MedicalXpress. For more details, images, and references:
Read Full Original Article ↗